Anastrozole-Impurities | Pharmaffiliates

anastrozole

Anastrozole was first approved for use in the United States in 1995.It is used in the treatment and prevention of breast cancer in women. Reference standards of Anastrozole API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Anastrozole (IPRS/119/12)-from IPC
    [catalogue_number] => PA IPIPRS 119 12
    [category_ids] => ,151,
    [chemical_name] => 
    [weight] => NA
    [form] => 
    [cas] => NA
    [pslug] => anastrozole-iprs-119-12-paipiprs11912
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA IPIPRS 119 12

Anastrozole (IPRS/119/12)-from IPC


  • Catalogue No.:PA IPIPRS 119 12

  • CAS :

    NA

  • Molecular Formula :

  • Molecular Weight : NA

stdClass Object
(
    [pname] => Anastrozole (IPRS/11/19)
    [catalogue_number] => PA IPRS 11 19
    [category_ids] => ,151,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => NA
    [pslug] => anastrozole-iprs-11-19-paiprs1119
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA IPRS 11 19

Anastrozole (IPRS/11/19)


  • Catalogue No.:PA IPRS 11 19

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA